Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	759.9	-1,844	-637.3	-3,628	4,254
Depreciation & Amortization	165.4	151.6	145.9	137.3	137.6
Loss (Gain) From Sale of Assets	-	-	-2.5	-1.4	-
Asset Writedown & Restructuring Costs	172.8	29.5	-	-	-
Loss (Gain) From Sale of Investments	-894.4	2,657	1,252	5,206	-4,925
Stock-Based Compensation	58	62.3	61.3	60.9	51.2
Other Operating Activities	-3.3	20	-12	22.1	8.74
Change in Accounts Receivable	19.6	16.2	11.4	-87.4	-20.4
Change in Inventory	68.9	8.5	-46.3	-158.8	46.1
Change in Accounts Payable	-0.1	-40.9	-51.8	-94.2	69.9
Change in Income Taxes	1.5	24.1	-21.3	-1.2	-28.8
Change in Other Net Operating Assets	12	-1.9	-2.2	-26.8	-8.6
Operating Cash Flow	532.2	455.2	374.9	194.4	669.5
Operating Cash Flow Growth	16.92%	21.42%	92.85%	-70.96%	14.44%
Capital Expenditures	-157.6	-165.6	-156.7	-112.8	-133.75
Sale of Property, Plant & Equipment	0.1	0.1	0.2	0.2	0.05
Cash Acquisitions	-218.5	-	-	-100.7	-125.52
Divestitures	-	-	2.5	1.4	-
Sale (Purchase) of Intangibles	-	-23.4	-	-1.5	-
Investment in Securities	186.3	28.7	174.2	-994.2	-84.73
Investing Cash Flow	-189.7	-160.2	20.2	-1,208	-797.38
Long-Term Debt Issued	-	-	-	1,186	-
Long-Term Debt Repaid	-0.5	-0.4	-0.5	-0.5	-3.02
Net Debt Issued (Repaid)	-0.5	-0.4	-0.5	1,186	-3.02
Issuance of Common Stock	15.8	19.2	18.5	17.6	20.63
Repurchase of Common Stock	-298.5	-207	-443.6	-229.7	-72.48
Other Financing Activities	-	-30.6	-	-	-0.56
Financing Cash Flow	-283.2	-218.8	-425.6	973.6	-55.43
Foreign Exchange Rate Adjustments	-16.9	9.2	0.4	3	-12.64
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0.04
Net Cash Flow	42.4	85.4	-30.1	-36.6	-195.98
Free Cash Flow	374.6	289.6	218.2	81.6	535.75
Free Cash Flow Growth	29.35%	32.72%	167.40%	-84.77%	12.45%
Free Cash Flow Margin	14.50%	11.28%	8.17%	2.91%	18.33%
Free Cash Flow Per Share	13.73	10.26	7.47	2.74	17.74
Cash Income Tax Paid	61.6	99.4	129.6	158.3	134.68
Levered Free Cash Flow	256.49	194.49	124.28	2.86	485.98
Unlevered Free Cash Flow	287.11	225.05	155.16	26.68	486.95
Change in Working Capital	272.4	-620.8	-432.8	-1,610	1,143

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q